Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 1
2013 2
2014 1
2015 2
2016 1
2017 3
2018 10
2019 6
2020 2
2021 6
2022 5
2023 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

33 results

Results by year

Filters applied: . Clear all
Page 1
Targeting MTHFR for the treatment of migraines.
Rainero I, Vacca A, Roveta F, Govone F, Gai A, Rubino E. Rainero I, et al. Among authors: govone f. Expert Opin Ther Targets. 2019 Jan;23(1):29-37. doi: 10.1080/14728222.2019.1549544. Epub 2018 Nov 28. Expert Opin Ther Targets. 2019. PMID: 30451038 Review.
Migraine: Genetic Variants and Clinical Phenotypes.
Rainero I, Vacca A, Govone F, Gai A, Pinessi L, Rubino E. Rainero I, et al. Among authors: govone f. Curr Med Chem. 2019;26(34):6207-6221. doi: 10.2174/0929867325666180719120215. Curr Med Chem. 2019. PMID: 30027842 Review.
Is Migraine Primarily a Metaboloendocrine Disorder?
Rainero I, Govone F, Gai A, Vacca A, Rubino E. Rainero I, et al. Among authors: govone f. Curr Pain Headache Rep. 2018 Apr 4;22(5):36. doi: 10.1007/s11916-018-0691-7. Curr Pain Headache Rep. 2018. PMID: 29619630 Review.
Signs and symptoms of COVID-19 in patients with multiple sclerosis.
Schiavetti I, Carmisciano L, Ponzano M, Cordioli C, Cocco E, Marfia GA, Inglese M, Filippi M, Radaelli M, Bergamaschi R, Immovilli P, Capobianco M, De Rossi N, Brichetto G, Scandellari C, Cavalla P, Pesci I, Confalonieri P, Perini P, Trojano M, Lanzillo R, Tedeschi G, Comi G, Battaglia MA, Patti F, Salvetti M, Sormani MP; MuSC-19 Study Group. Schiavetti I, et al. Eur J Neurol. 2022 Dec;29(12):3728-3736. doi: 10.1111/ene.15554. Epub 2022 Sep 23. Eur J Neurol. 2022. PMID: 36086905 Free PMC article.
Response to a letter to the editor.
Rubino E, Zhang M, Mongini T, Boschi S, Vercelli L, Vacca A, Govone F, Gai A, Giordana MT, Grinberg M, Rogaeva E, Rainero I. Rubino E, et al. Among authors: govone f. Neurobiol Aging. 2019 Jun;78:195-196. doi: 10.1016/j.neurobiolaging.2019.02.015. Epub 2019 Mar 1. Neurobiol Aging. 2019. PMID: 31027854 No abstract available.
Therapeutic choices and disease activity after 2 years of treatment with cladribine: An Italian multicenter study (CladStop).
Schiavetti I, Signori A, Albanese A, Frau J, Cocco E, Lorefice L, di Lemme S, Fantozzi R, Centonze D, Landi D, Marfia G, Signoriello E, Lus G, Zecca C, Gobbi C, Iodice R, Malimpensa L, Cordioli C, Ferraro D, Ruscica F, Pasquali L, Repice A, Immovilli P, Ferrò MT, Bonavita S, Di Filippo M, Abbadessa G, Govone F, Sormani MP; CladStop study group. Schiavetti I, et al. Among authors: govone f. Eur J Neurol. 2024 Mar 28:e16250. doi: 10.1111/ene.16250. Online ahead of print. Eur J Neurol. 2024. PMID: 38549186
COVID-19 Severity in Multiple Sclerosis: Putting Data Into Context.
Sormani MP, Schiavetti I, Carmisciano L, Cordioli C, Filippi M, Radaelli M, Immovilli P, Capobianco M, De Rossi N, Brichetto G, Cocco E, Scandellari C, Cavalla P, Pesci I, Zito A, Confalonieri P, Marfia GA, Perini P, Inglese M, Trojano M, Brescia Morra V, Tedeschi G, Comi G, Battaglia MA, Patti F, Salvetti M; MuSC-19 Study Group. Sormani MP, et al. Neurol Neuroimmunol Neuroinflamm. 2021 Nov 9;9(1):e1105. doi: 10.1212/NXI.0000000000001105. Print 2022 Jan. Neurol Neuroimmunol Neuroinflamm. 2021. PMID: 34753829 Free PMC article.
High Risk of Suicide in Behavioral Variant Frontotemporal Dementia.
Zucca M, Rubino E, Vacca A, Govone F, Gai A, De Martino P, Boschi S, Gentile S, Giordana MT, Rainero I. Zucca M, et al. Among authors: govone f. Am J Alzheimers Dis Other Demen. 2019 Jun;34(4):265-271. doi: 10.1177/1533317518817609. Epub 2018 Dec 17. Am J Alzheimers Dis Other Demen. 2019. PMID: 30558441 Free PMC article.
Disease-Modifying Therapies and Coronavirus Disease 2019 Severity in Multiple Sclerosis.
Sormani MP, De Rossi N, Schiavetti I, Carmisciano L, Cordioli C, Moiola L, Radaelli M, Immovilli P, Capobianco M, Trojano M, Zaratin P, Tedeschi G, Comi G, Battaglia MA, Patti F, Salvetti M; Musc-19 Study Group. Sormani MP, et al. Ann Neurol. 2021 Apr;89(4):780-789. doi: 10.1002/ana.26028. Epub 2021 Feb 9. Ann Neurol. 2021. PMID: 33480077 Free PMC article.
SARS-CoV-2 serology after COVID-19 in multiple sclerosis: An international cohort study.
Sormani MP, Schiavetti I, Landi D, Carmisciano L, De Rossi N, Cordioli C, Moiola L, Radaelli M, Immovilli P, Capobianco M, Brescia Morra V, Trojano M, Tedeschi G, Comi G, Battaglia MA, Patti F, Fragoso YD, Sen S, Siva A, Furlan R, Salvetti M; MuSC-19 Study Group. Sormani MP, et al. Mult Scler. 2022 Jun;28(7):1034-1040. doi: 10.1177/13524585211035318. Epub 2021 Jul 30. Mult Scler. 2022. PMID: 34328824
33 results